Navigation Links
Predicting risk of arrhythmias and sudden cardiac death: There's a computer model for that
Date:12/13/2012

A computer model of the heart wall predicted risk of irregular heart rhythms and sudden cardiac death in patients, paving the way for the use of more complex cardiac models to calculate the consequences of genetic, lifestyle and other changes to the heart.

Authors of the new study, published in the Journal of the American College of Cardiology, say this is the first report of cardiac modeling being used as an arrhythmic risk predictor for patients.

"This is a strong proof-of-principle study showing that computer simulation can be used to predict risk of cardiac arrhythmias," said Coeli M. Lopes, Ph.D., lead study author and assistant professor at the Aab Cardiovascular Research Institute at the University of Rochester Medical Center. "With this model we can determine the influence of a single mutation on the much bigger overall response of the heart."

With this study under their belts, the research team, including several scientists from the Medical Center, the IBM T.J. Watson Research Center in Yorktown Heights, N.Y and the IBM Research Collaboratory for Life Sciences in Melbourne, Australia is pursuing a much more sophisticated model of the whole human heart. They plan to predict the effects of new drugs on the electrical activity of the heart one of the most challenging hurdles in the development of new drugs and an extremely important part of keeping potentially dangerous drugs off the market.

The computer model, designed by IBM scientists Matthias Reumann, Ph.D., and J. Jeremy Rice, Ph.D., includes 192 heart cells made to function electrically like the ventricle wall by assigning varying properties to cells based on their position inside, middle, or outside in the heart wall. The IBM scientists used canine cardiac cells as a guide, adapting the model cells to act more like ours based on extensive data on the electrical properties of the human heart. In the end, the simulation requires the solution of more than 100,000 complex mathematical equations at least 1,000 times over just to simulate a single heartbeat.

The team turned to more than 600 patients with Long QT syndrome type 1 an inherited disorder that puts patients at greater risk of arrhythmias and sudden cardiac death to help test the model. Patients were drawn from Long QT syndrome registries from the United States, Japan, the Netherlands, Denmark and Sweden.

Patients with the disorder have mutations in a specific gene, KCNQ1, which helps heart cells appropriately generate and transmit electrical signals. The study used 34 different mutations to the gene, identified with patient blood samples and genetic tests. To better understand the characteristics of each mutation how they act and the defects they cause the team recreated all of the mutant proteins in the lab and tested them in various cell lines.

Researchers plugged each mutation's electrical profile into the model to simulate the mutation's effect on the heart wall. The model produced a one-dimensional, transmural (across the heart wall) electrocardiogram or ECG for each mutation, which predicts how the mutation influences the electrical properties of the heart wall as it is excited and relaxes after each beat.

When the team compared this information to patient data, analyses revealed that mutations the model predicted would strongly prolong repolarization the time it takes for the heart wall to recover after each beat put patients at greater risk of potentially life-threatening events. For every 10 milliseconds that repolarization was delayed a patient's risk of sudden cardiac death or aborted cardiac arrest rose by approximately one third.

The authors note that this risk is separate from the increased risk observed for patients that show a very prolonged repolarization on traditional ECGs, when electrodes are placed on the skin and attached to a machine that records the heart's electrical signals. They suggest that the computer simulation may reflect a lifelong risk of heart rhythm problems, while the conventional ECG may show only a single point in time.

They identified four high-risk mutations that were predicted to have particularly extended repolarization periods and determined that patients with these mutations experienced the greatest number of cardiac events.

Study authors say the results show that a relatively simple model, used in the right hands with the proper experimental data, can give insight into complex ECGs from real patients. "Using this model, we can predict the likelihood that an individual will experience a deadly cardiac event based on the type of mutation they have and how that mutation acts," noted Lopes.

Rice, a seasoned cardiac modeler that led the IBM team, adds, "This is a very powerful study because we used so many different mutations. Oftentimes, scientists will study only one mutation at a time, and the research community remains unconvinced as the right answer may have come by luck. By comparing our results to so much patient data, we've shown that you can get meaningful information out of computer models, hopefully paving the way for wider acceptance and use in the medical community."

Arthur J. Moss, M.D., a world-renowned expert on electrical disturbances of the heart, says that research has shown that the location of a mutation plays an important role in assessing risk, but this is the first time scientists have used the function of a mutation to identify patients at higher risk.

"This kind of movement, from identifying a mutation, to locating where it is, and now to evaluating how the mutation functions, is going to happen in every area of medicine, from heart disease to cancer," said Moss, a study author and longtime professor of Cardiology at the University of Rochester Medical Center. "This type of knowledge is going to help us better predict risk for each individual patient and provide more aggressive prevention and treatment strategies for those who need it."

Moss adds that the research exemplifies a strong trend in medicine where practitioners are moving away from diagnosing disease primarily by signs and symptoms and instead focusing more on the basic genetic aspects of specific ailments.

Computer models of the human heart have been in development since the 1960's, but the authors believe they are the first to publish a study demonstrating that they can be used to generate clinically relevant information that predicts patient risk.

Lopes and Rice, along with Jean-Phillippe Couderc, Ph.D., M.B.A., a biomedical engineer and cardiology researcher at the Medical Center, are taking their model to the next level with the use of IBM's next generation supercomputer, the Blue Gene/Q, which was recently installed in the University of Rochester's Health Sciences Center for Computational Innovation. It is one of the most powerful and efficient computer systems in the world and enables scientists to sift through mountains of data and create complex models. The team plans on using the supercomputer to generate a gender-specific model to better understand which drugs may cause lethal disruptions of the heart's electrical activity.


'/>"/>

Contact: Emily Boynton
emily_boynton@urmc.rochester.edu
585-273-1757
University of Rochester Medical Center
Source:Eurekalert

Related medicine news :

1. Combining diagnostic tests more accurate at predicting Alzheimers
2. Valuable tool for predicting pain genes in people
3. Predicting, preventing, and controlling pandemics: Making the case for a strategic action plan
4. Researchers develop non-invasive technique for predicting patients response to chemotherapy
5. Study uncovers simple way of predicting severe pain following breast cancer surgery
6. A new model for predicting recovery after spinal cord injury
7. Predicting post-traumatic stress disorder before it happens
8. Study examines BI-RADS and MRI in predicting breast cancer
9. Fine tuning cardiac ablation could lead to quicker results for patients with arrhythmias
10. Discovery in Ghent could improve screening for sudden cardiac death
11. Even Light Smoking Boosts Womens Risk of Sudden Heart Death: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Comfort ... the American Cancer Society and the Road To Recovery® program to drive cancer patients ... seniors and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- Research and Markets has announced ... Applications, Technologies, Forecasts" report to their offering. ... Smart Skin, Structural Health Monitoring, Composite Smart Structures, ... involves electronic and/or electrical components and circuits that ... such as vehicle bodies or conformally placed upon ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June ... -based mobile pulmonary function testing company, is now able to ... devices developed by ndd Medical Technologies , Inc. ... done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ... , can get any needed testing done in the comfort of ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
Breaking Medicine Technology: